Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi

Waning of antibody levels induced by a 13-valent pneumococcal

Frontiers Immunogenicity and Efficacy of Pneumococcal Conjugate

Effectiveness of the 13-valent pneumococcal conjugate vaccine

Quality of antibody responses by adults and young children to 13

Vaccines, Free Full-Text

Longitudinal kinetics of neutralizing antibodies against

British HIV Association Guidelines on the Use of Vaccines in HIV

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical

Frontiers Safety and Efficacy of Pneumococcal Vaccination in

Quality of antibody responses by adults and young children to 13

Frontiers Diagnostic Vaccination in Clinical Practice